ZS Pharma Receives $46,000,000 Series C Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c1f4d1c5-1db3-41bb-805a-f63414a6eaa8&Preview=1 - Date
10/26/2012 - Company Name
ZS Pharma - Mailing Address
1120 South Freeway Fort Worth, TX 76104 - Company Description
Founded in 2008, ZS Pharma, Inc. is a privately held specialty pharmaceutical company located inFort Worth, Texas. It is focused on the development and commercialization of proprietary oral sorbent technology that will significantly improve the clinical outcomes of those patients suffering from toxic conditions associated with kidney and liver disease. - Website
http://www.zspharma.com - Transaction Type
Venture Equity - Transaction Amount
$46,000,000 - Transaction Round
Series C - Proceeds Purposes
The funding will allow ZS Pharma to proceed with pivotal trials for ZS-9 as it prepares for commercialization of the product. - M&A Terms
- Venture Investor
Alta Partners - Venture Investor
RiverVest Venture Partners - Venture Investor
Devon Park Bioventures - Venture Investor
3×5 Special Opportunity Partners - Venture Investor
Salem Partners
